ADVISORY RESEARCH INC Supernus Pharmaceuticals, Inc. Transaction History

ADVISORY RESEARCH INC portfolio value:

$905,000
portfolio value

ADVISORY RESEARCH INC quarter portfolio value change:

+17.05%
quarter

Supernus Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +0.35% 93 shares 135K $33.85 26.72K
Q2 2022 share Increase +9.90% 2.4K shares -13K $28.92 26.63K
Q1 2022 share Increase 0.00% 24.23K shares 783K $32.32 24.23K